Impairment of anti-platelet-aggregating activit of endothelial cells after experimental subarachnoid hemorrhage

Stroke

Volumn 24, Issue 10, 1993, Pages 1541-1545

  Ohkuma, Hiroki ^a   Ogane, Kazumi ^a   Fujita, Seiichiro ^a   Manabe, Hiroshi ^a   Suzuki, Shigeharu ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Cats; Cerebral vasospasm; Endothelium; Platelet aggregation; Subarachnoid hemorrhage

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASILAR ARTERY; BRAIN ISCHEMIA; BRAIN VASOSPASM; CAT; CONTROLLED STUDY; ENDOTHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; VERTEBRAL ARTERY;

ADENOSINE DIPHOSPHATE; ANIMAL; BALLOON DILATATION; CATS; ENDOTHELIUM, VASCULAR; MICROSCOPY, ELECTRON, SCANNING; PLATELET ADHESIVENESS; PLATELET AGGREGATION; SUBARACHNOID HEMORRHAGE; TIME FACTORS;

EID: 0027358793     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/01.STR.24.10.1541     Document Type: Article

References (22)

1. Kassell NF, Sasaki T, Colohan ART, Nazar G. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke. 1985;16: 562-572.
2. Juvella S, Hillbom M, Kaste M. Platelet thromboxane release and delayed cerebral ischemia in patients with subarachnoid hemorrhage. J Neurosurg. 1991;74:386-392.
3. Ohkuma H, Suzuki S, Kimura M, Sobata E. Role of platelet function in symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke. 1991;22:854-859.
4. Suzuki S, Sobata E, Andoh A, Iwabuchi T. Role of multiple cerebral microthrombosis in symptomatic cerebral vasospasm: with a case report. Neurosurgery. 1983;13:199-203.
5. Suzuki S, Kimura M, Souma M, Ohkuma H, Shimizu T, Iwabuchi T. Cerebral microthrombosis in symptomatic cerebral vasospasm: a quantitative histological study in autopsy cases. Neurol Med Chir (Tokyo). 1990;30:309-316.
6. Sasaki T, Wakai S, Asano T, Takakura K, Sano K. Prevention of cerebral vasospasm after SAH with thromboxane synthetase inhibitor, OKY-1581. J Neurosurg. 1982;57:74-82.
7. Fein JM, Flor WJ, Cohan SL, Parkhurst J. Sequential changes of vascular ultrastructure in experimental vasospasm. J Neurosurg. 1974;41:49-58.
8. Tanabe Y, Sakata K, Yamada H, Ito T, Takada M. Cerebral vasospasm and ultrastructural changes in cerebral arterial wall. J Neurosurg. 1978;49:229-238.
9. Sasaki T, Kassell NF, Yamashita M, Fujiwara S, Zuccarello M. Barrier disruption in the major cerebral arteries following experimental subarachnoid hemorrhage. J Neurosurg. 1985;63:433 -440.
10. Boullin DJ, Bunting S, Blaso WP, Hunt TM, Moncada S. Response of human and baboon arteries to prostaglandin endoperoxides and biologically generated and synthetic prostacyclin: their relevance to cerebral arterial spasm in man. Br J Clin Pharmacol. 1979;7: 139-149.
11. Kanamaru K, Waga S, Kojima T, Fujimoto K, Niwa S. Endotheliumdependent relaxation of canine basilar arteries, II: inhibition by hemoglobin and cerebrospinal fluid from patients with aneurysmal subarachnoid hemorrhage. Stroke. 1987;18:938-943.
12. Maeda Y, Tani E, Miyamoto T. Prostaglandin metabolism in experimental cerebral vasospasm. J Neurosurg. 1981;55:779-785.
13. Nakagomi T, Kassell NF, Sasaki T, Fujiwara S, Lehman RM, Johshita H, Nazar GB, Torner J. Effect of subarachnoid hemorrhage on endothelium-dependent vasodilation. J Neurosurg. 1987;66:915 -923.
14. Nakamura S, Yoshida K, Tsubokawa T. Regional disparity in the vascular response to subarachnoid hemorrhage: relationship between alteration of the concentration of eicosanoids and electron microscopic findings. Neurol Med Chir (Tokyo). 1989;29: 181-186.
15. Nosko M, Shultz R, Weir B, Cook DA, Phil D, Grace M. Effects of vasospasm on levels of prostacyclin and thromboxane A2 in cerebral arteries of the monkey. Neurosurgery. 1988;22:45 -50.
16. Sasaki T, Murota S, Wakai S, Asano T, Sano K. Evaluation of prostaglandin biosynthetic activity in canine basilar artery following subarachnoid injection of blood. J Neurosurg. 1981;55: 771-778.
17. Nishimura H, Rosenblum WI, Helson GH, Boynton S. Agents that modify EDRF formation alter antiplatelet properties of brain arteriolar endothelium in vivo. Am J Physiol. 1991;261:H15-H21.
18. Moncada S, Gryglewski R, Bunting S, Vane JR. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature. 1976;263:663-665.
19. Weiss HJ, Turitto VT. Prostacyclin (prostaglandin I2, PGI2) inhibits platelet adhesion and thrombus formation on subendothelium. Blood. 1979;53:244-250.
20. Fieschi C, Battistini N, Volante F, Zanette E, Weber G, Pssero S. Animal model of TIA: an experimental study with intracarotid ADP infusion in rabbits. Stroke. 1975;6:617-621.
21. Fujimoto T, Suzuki H, Tanoue K, Fukushima Y, Yamazaki H. Cerebrovascular injuries induced by activation of platelets in vivo. Stroke. 1985;16:245-250.
22. Suzuki S, Sano K, Handa H, Asano T, Tamura A, Yonekawa Y, Ono H, Tachibana N, Hanaoka K. Clinical study of OKY-046, a thromboxane synthetase inhibitor, in prevention of cerebral vasospasms and delayed cerebral ischaemic symptoms after subarachnoid haemorrhage due to aneurysmal rupture: a randomized double-blind study. Neurol Res. 1989;11:79-88.